Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone

Vaccine

Volumn 22, Issue 20, 2004, Pages 2599-2608

  Mutoh, Eiji ^a   Ishikawa, Toyokazu ^b   Takamizawa, Akihisa ^b   Kurata, Takeshi ^a   Sata, Tetsutaro ^a   Kojima, Asato ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Japanese encephalitis virus; Subunit vaccine; Virus like particle

Indexed keywords

ADJUVANT; JAPANESE ENCEPHALITIS VACCINE; M PROTEIN; NEUTRALIZING ANTIBODY; SUBUNIT VACCINE; VIRUS ANTIGEN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CELL CLONE; CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; HEMAGGLUTINATION; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SUCROSE GRADIENT; ULTRAFILTRATION; VIRUS ENCEPHALITIS; VIRUS INFECTION; VIRUS PARTICLE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CLONE CELLS; CULTURE MEDIA, SERUM-FREE; ENCEPHALITIS VIRUS, JAPANESE; FEMALE; JAPANESE ENCEPHALITIS VACCINES; MICE; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 2942590398     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.12.008     Document Type: Article

References (37)

1. Hanna J.N., Ritchie S.A., Phillips D.A., Shield J., Bailey M.C., Mackenzie J.J., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med. J. Aust. 165:1996;256-260
2. Mackenzie J.S., Johansen C.A., Ritchie S.A., Hurk A.F., Hall R.A. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australia. Curr. Top Microbiol. Immunol. 267:2002;49-74
3. Endy T.P., Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr. Top Microbiol. Immunol. 267:2002;11-48
4. Igarashi A. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control. Curr. Top. Microbiol. Immunol. 267:2002;139-152
5. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI Meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine. 18:2000;1-25
6. Chambers T.J., Tsai T.F., Pervikov Y., Monath T.P. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization Meeting. Vaccine. 15:1997;1494-1502
7. Ishikawa T., Yoshii H., Onishi T., Ishibashi M., Imagawa T. Development of an inactivated Japanese encephalitis vaccine by utilizing a continuous cell line. Clin. Virol. 26:1998;340-350
8. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine. 19:2001;4557-4565
9. Sugawara K., Nishiyama K., Ishikawa Y., Abe M., Sonoda K., Komatsu K., et al. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals. 30:2002;303-314
10. Kinney R.M., Huang C.Y.H. Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology. 44:2001;176-197
11. Monash T.P. Japanese encephalitis vaccines: current vaccines and future prospects. Curr. Top. Microbiol. Immunol. 267:2002;105-138
12. Lin Y.L., Liao C.L., Yeh C.T., Chang C.H., Huang Y.L., Huang Y.Y., et al. A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice. Virus Res. 44:1996;45-56
13. Konishi E., Pincus S., Paoletti E., Shope R.E., Burrage T., Mason P.W. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology. 188:1992;714-720
14. Yasuda A., Kimura-Kuroda J., Ogimoto M., Miyamoto M., Sata T., Sato T., et al. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express prM and E glycoproteins of Japanese encephalitis virus. J. Virol. 64:1990;2788-2795
15. Chambers T.J., Nestorowicz A., Mason P.W., Rice C.M. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J. Virol. 73:1999;3095-3101
16. Guirakhoo F., Zhang Z.X., Chambers T.J., Delagrave S., Arroyo J., Barrett A.D., et al. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology. 257:1999;363-372
17. Monath T.P., Levenbook I., Soike K., Zang Z.X., Ratterree M., Draper K., et al. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:2000;1742-1751
18. Chang G.J., Hunt A.R., Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J. Virol. 74:2000;4244-4252
19. Konishi E., Yamaoka M., Win K.S., Kurane I., Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 72:1998;4925-4930
20. Heinz F.X., Allison S.L. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55:2000;231-269
21. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed., vol. 1. Philadelphia, Lippincott: Williams & Wilkins; 2001. p. 991-1041.
22. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J. Virol. 73:1999;10137-10145
23. Kimura-Kuroda J., Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141:1988;3606-3610
24. Kurane I. Immune responses to Japanese encephalitis virus. Curr. Top. Microbiol. Immunol. 267:2002;91-103
25. Mason P.W., Dalrymple J.M., Gentry M.K., McCown J.M., Hoke C.H., Burke D.S., et al. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:1989;2037-2049
26. Konishi E., Mason P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67:1993;1672-1675
27. Sato T., Takamura C., Yasuda A., Miyamoto M., Kamogawa K., Yasui K. High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by NS3 gene product. Virology. 192:1993;483-490
28. Mason P.W., Zugel M.U., Semproni A.R., Fournier M.J., Mason T.L. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherihia coli. J. Gen. Virol. 71:1990;2107-2114
29. Fujita H., Sumiyoshi H., Mori C., Manabe S., Takagi M., Yoshida I., et al. Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast. Bull. World Health Organ. 65(3):1987;303-308
30. Konishi E., Fujii A., Mason P.W. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J. Virol. 75:2001;2204-2212
31. Guirakhoo F., Heinz F.X., Mandl C.W., Holzmann H., Kunz C. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72:1991;1323-1329
32. Schalich J., Allison S.L., Stiasny K., Mandl C.W., Kunz C., Heinz F.X. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 70:1996;4549-4557
33. Kojima A., Yasuda A., Asanuma H., Ishikawa T., Takamizawa A., Yasui K., et al. Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus E protein for a second-generation subunit vaccine. J. Virol. 77:2003;8745-8755
34. Clarke D.H., Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne viruses. Am. J. Trop. Med. Hyg. 7:1958;561-573
35. Hoshikawa N., Kojima A., Yasuda A., Takayashiki E., Masuko S., Chiba J., et al. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. J. Gen. Virol. 67:1991;2509-2517
36. Matsuura Y., Miyamoto M., Sato T., Morita T., Yasui K. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology. 173:1989;674-682
37. Venugopal K., Gould E.A. Towards a new generation of flavivirus vaccines. Vaccine. 12(11):1994;966-975